Chenghong Peng
Overview
Explore the profile of Chenghong Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
2536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, Wang Y, Jiang K, Xu Z, Jiang Y, Wu Z, et al.
Ann Surg
. 2024 Feb;
280(2):222-228.
PMID: 38385254
Objective: To evaluate the effect of perioperative dexamethasone on postoperative complications after pancreaticoduodenectomy. Background: The glucocorticoid dexamethasone has been shown to improve postoperative outcomes in surgical patients, but its effects...
2.
Ou H, Chen M, Qin K, Zhao S, Li D, Shi Y, et al.
Ann Surg
. 2024 Jan;
PMID: 38258584
Objective: To assess short-term and long-term outcomes following robotic enucleation (REn) of tumors in the proximal pancreas. Background: Despite the advantages of preserving function via pancreatic enucleation, controversies persist, since...
3.
Chen H, Weng Y, Zhao S, Wang W, Ji Y, Peng C, et al.
Surg Endosc
. 2023 Dec;
38(2):821-829.
PMID: 38066192
Background: Studies have demonstrated that the learning curve plays an important role in robotic pancreatoduodenectomy (RPD). Although improved short-term outcomes of RPD after the learning curve have been reported compared...
4.
Cao Y, Wang X, Liu Y, Liu P, Qin J, Zhu Y, et al.
Adv Sci (Weinh)
. 2023 Dec;
11(7):e2306298.
PMID: 38064101
Pancreatic cancer (PCa) is one of the most fatal human malignancies. The enhanced infiltration of stromal tissue into the PCa tumor microenvironment limits the identification of key tumor-specific transcription factors...
5.
Feng Z, Li K, Qin K, Liang J, Shi M, Ma Y, et al.
J Hematol Oncol
. 2023 Nov;
16(1):109.
PMID: 37908024
No abstract available.
6.
Xue M, Zhu Y, Jiang Y, Han L, Shi M, Su R, et al.
Nat Commun
. 2023 Jul;
14(1):4600.
PMID: 37524695
Neuropathy is a feature more frequently observed in pancreatic ductal adenocarcinoma (PDAC) than other tumors. Schwann cells, the most prevalent cell type in peripheral nerves, migrate toward tumor cells and...
7.
Chen D, Cao Y, Tang H, Zang L, Yao N, Zhu Y, et al.
Theranostics
. 2023 Jun;
13(10):3290-3309.
PMID: 37351165
: Accumulating evidence illustrated that the reprogramming of the super-enhancers (SEs) landscape could promote the acquisition of metastatic features in pancreatic cancer (PC). Given the anatomy-based TNM staging is limited...
8.
Ai Q, Li F, Zou S, Zhang Z, Jin Y, Jiang L, et al.
Front Immunol
. 2023 Jun;
14:1161538.
PMID: 37287989
KRAS mutation is a significant driving factor of tumor, and KRAS mutation has the highest incidence in solid tumors such as pancreatic cancer and colorectal cancer. Thus, KRAS neoantigen-specific TCR-engineered...
9.
Li J, Qian L, Shi Y, Shen B, Peng C
Cancer Med
. 2023 May;
12(14):15141-15148.
PMID: 37255405
Background: High body mass index was considered as a risk factor for minimally invasive surgery. The short-term outcomes of robot-assisted pancreaticoduodenectomy (RPD) remain controversial. This study aims to investigate the...
10.
Wen C, Zhang L, Yang Y, Jin Y, Ren D, Zhang Z, et al.
Int J Surg
. 2023 Apr;
109(7):1941-1952.
PMID: 37026827
Background: Patients with resected pancreatic adenocarcinoma (PAAD) often experience short-term relapse and dismal survival, suggesting an urgent need to develop predictive and/or prognostic biomarkers for these populations. Given the potential...